We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Amdocs
DOX
$6.23B
| $508K | ﹤0.01% |
6,399
+1,188
| +23% | +$101K |
|
1927
Sonoco
SON
$5.77B
| $507K | ﹤0.01% |
8,943
+2,350
| +36% | +$144K |
|
1928
Spire
SR
$4.9B
| $507K | ﹤0.01% |
8,140
+1,431
| +21% | +$102K |
|
|
POWR
1929
iShares U.S. Power Infrastructure ETF
POWR
$464M
| $506K | ﹤0.01% |
23,701
-4,234
| -15% | -$93.9K |
|
1930
Invesco KBW Bank ETF
KBWB
$6.84B
| $506K | ﹤0.01% |
10,297
+324
| +3% | +$17.7K |
|
1931
National Fuel Gas
NFG
$7.75B
| $505K | ﹤0.01% |
8,206
+1,209
| +17% | +$83.4K |
|
1932
HubSpot
HUBS
$12B
| $503K | ﹤0.01% |
1,861
-38
| -2% | -$12.1K |
|
|
CMA
1933
DELISTED
Comerica
CMA
| $502K | ﹤0.01% |
7,065
+984
| +16% | +$77.5K |
|
1934
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$175M
| $502K | ﹤0.01% |
12,333
-488
| -4% | -$22.8K |
|
1935
Cogent Communications
CCOI
$530M
| $501K | ﹤0.01% |
9,597
+505
| +6% | +$29.1K |
|
|
BTO
1936
John Hancock Financial Opportunities Fund
BTO
$819M
| $500K | ﹤0.01% |
15,849
-1,958
| -11% | -$71.2K |
|
1937
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$745M
| $500K | ﹤0.01% |
20,609
+757
| +4% | +$21K |
|
1938
Vericel Corp
VCEL
$2.28B
| $500K | ﹤0.01% |
21,552
-194
| -0.9% | -$5.29K |
|
1939
iShares MSCI Japan ETF
EWJ
$23.2B
| $499K | ﹤0.01% |
10,205
-625
| -6% | -$33.5K |
|
1940
Dime Commercial Bancshares
DCOM
$1.82B
| $498K | ﹤0.01% |
17,001
-1,670
| -9% | -$53.2K |
|
1941
Schwab Fundamental US Small Company Index ETF
FNDA
$9.43B
| $497K | ﹤0.01% |
23,378
+4,588
| +24% | +$109K |
|
1942
First Trust Low Duration Strategic Focus ETF
LDSF
$163M
| $497K | ﹤0.01% |
27,057
-46,034
| -63% | -$866K |
|
1943
Raymond James Financial
RJF
$34.8B
| $497K | ﹤0.01% |
5,024
+1,119
| +29% | +$113K |
|
|
MASI
1944
DELISTED
Masimo
MASI
| $496K | ﹤0.01% |
3,512
+290
| +9% | +$42.4K |
|
1945
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70M
| $494K | ﹤0.01% |
21,408
-501
| -2% | -$13K |
|
|
IGR
1946
CBRE Global Real Estate Income Fund
IGR
$715M
| $494K | ﹤0.01% |
85,563
+4,005
| +5% | +$29.3K |
|
1947
Jazz Pharmaceuticals
JAZZ
$16B
| $492K | ﹤0.01% |
3,694
+34
| +0.9% | +$5.17K |
|
1948
Middlesex Water
MSEX
$1.11B
| $492K | ﹤0.01% |
6,368
+414
| +7% | +$37.1K |
|
1949
Fidelity Limited Term Bond ETF
FLTB
$436M
| $489K | ﹤0.01% |
10,269
-1
| -0% | -$49 |
|
1950
Bath & Body Works
BBWI
$3.76B
| $488K | ﹤0.01% |
14,976
-1,531
| -9% | -$54K |
|
Similar funds
LP
HF
RIM
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.